68
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study

, , , &
Pages 41-45 | Published online: 07 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yueyue Li, Anni Chen, Hui Wang, Lu Han, Rong Wang, Guoqing Zhang & Yongfang Yuan. (2021) Treatment Adherence to Nucleos(t)ide Analogs in Chinese Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Single-Center Cross-Sectional Study. Patient Preference and Adherence 15, pages 1729-1738.
Read now
Liguo Wang, Peng Chen & Chao Zheng. (2018) Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B. Infection and Drug Resistance 11, pages 2179-2185.
Read now
Shaohang Cai, Zhandong Li, Tao Yu, Muye Xia & Jie Peng. (2018) Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs. Infection and Drug Resistance 11, pages 469-477.
Read now
Xiulan Xue, Shaohang Cai, Hongjie Ou, Caixia Zheng & Xiaolu Wu. (2017) Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment. Patient Preference and Adherence 11, pages 85-93.
Read now

Articles from other publishers (15)

Xuemei Tao, Lin Chen, Youfei Zhao, Yonggang Liu, Ruifang Shi, Bei Jiang, Yuqiang Mi & Liang Xu. (2022) A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease. Frontiers in Medicine 9.
Crossref
Nicole L. Allard, Jennifer H. MacLachlan, Anouk Dev, James Dwyer, Geeta Srivatsa, Timothy Spelman, Alexander J. Thompson & Benjamin C. Cowie. (2020) Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes. BMC Gastroenterology 20:1.
Crossref
Spilios Manolakopoulos, Athanasia Striki, Vasilios Papastergiou, Nikoleta Perlepe, Konstantinos Zisimopoulos, Afroditi Papazoglou, Melanie Deutsch, Nikolaos Papadopoulos, Christos Triantos, John Goulis & George Papatheodoridis. (2020) Persistence and adherence to nucleos(t)ide analogues in chronic hepatitis B: a multicenter cohort study. European Journal of Gastroenterology & Hepatology 32:5, pages 635-641.
Crossref
Urbano Sbarigia, Furaha Kariburyo, Janvi Sah, Jamie Colasurdo, Lin Xie, Eva G. Katz & Shirley Sylvester. (2020) Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans Population. Advances in Therapy 37:3, pages 1156-1172.
Crossref
Zhidan Zheng, Wei Liao, Lili Liu, Shaohang Cai, Haipeng Zhu & Sichun Yin. (2020) Effect of nucleos(t)ide analogue on serum HBsAg level in chronic hepatitis B patients: A 3-years study. Biomedicine & Pharmacotherapy 122, pages 109698.
Crossref
Hongxia Liu & Linqing Yang. (2019) Dynamic change of depression and anxiety after chemotherapy among patients with ovarian cancer. Medicine 98:31, pages e16620.
Crossref
Jing Sun, Yanfang Li, Xuying Sun, Youde Liu, Danxia Zheng & Lijuan Fan. (2019) Association between abdominal obesity and liver steatosis and fibrosis among patients with chronic hepatitis B measured by Fibroscan. Experimental and Therapeutic Medicine.
Crossref
Jing Sun, Yanfang Li, Xuying Sun, Hong Yu & Youde Liu. (2018) Dynamic Changes of the Aspartate Aminotransferase‐to‐Platelet Ratio and Transient Elastography in Predicting a Histologic Response in Patients With Chronic Hepatitis B After Entecavir Treatment. Journal of Ultrasound in Medicine 38:6, pages 1441-1448.
Crossref
Qi Chen, Chunni Cao, Li Gong & Yanxiang Zhang. (2019) Health related quality of life in stroke patients and risk factors associated with patients for return to work. Medicine 98:16, pages e15130.
Crossref
Suzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Jacob George, Amany Zekry & Lisa Maher. (2017) Factors Associated with Non-Adherence to HBV Antiviral Therapy. Antiviral Therapy 23:5, pages 425-433.
Crossref
Xiumei Wang, Weiwei Zhang, Youde Liu, Wenjing Gong, Ping Sun, Xiangshuo Kong, Miaomiao Yang & Zhihua Wang. (2017) Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma. Infectious Agents and Cancer 12:1.
Crossref
Shaohang Cai, Jiawei Cao, Tao Yu, Muye Xia & Jie Peng. (2017) Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine. Medicine 96:22, pages e7021.
Crossref
Hongjie Ou, Shaohang Cai, Ying Liu, Muye Xia & Jie Peng. (2016) A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B. Therapeutic Advances in Gastroenterology 10:2, pages 207-217.
Crossref
N. Allard, A. Dev, J. Dwyer, G. Srivatsa, A. Thompson & B. Cowie. (2017) Factors associated with poor adherence to antiviral treatment for hepatitis B. Journal of Viral Hepatitis 24:1, pages 53-58.
Crossref
Xiaolu Wu, Shaohang Cai, Zhandong Li, Caixia Zheng, Xiulan Xue, Jianyong Zeng & Jie Peng. (2016) Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis. Virology Journal 13:1.
Crossref